These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31112361)

  • 1. Short lookback periods causing exaggerated stroke risk estimates in atrial fibrillation may expose patients to unnecessary anticoagulant treatment.
    Friberg L
    Pharmacoepidemiol Drug Saf; 2019 Aug; 28(8):1054-1059. PubMed ID: 31112361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do physicians correctly calculate thromboembolic risk scores? A comparison of concordance between manual and computer-based calculation of CHADS2 and CHA2 DS2 -VASc scores.
    Esteve-Pastor MA; Marín F; Bertomeu-Martinez V; Roldán-Rabadán I; Cequier-Fillat Á; Badimon L; Muñiz-García J; Valdés M; Anguita-Sánchez M;
    Intern Med J; 2016 May; 46(5):583-9. PubMed ID: 26929032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of CHA
    Hjelholt TJ; Johnsen SP; Brynningsen PK; Pedersen AB
    J Am Geriatr Soc; 2020 Aug; 68(8):1698-1705. PubMed ID: 32294240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refinement of ischemic stroke risk in patients with atrial fibrillation and CHA2 DS2 -VASc score of 1.
    Huang D; Anguo L; Yue WS; Yin L; Tse HF; Siu CW
    Pacing Clin Electrophysiol; 2014 Nov; 37(11):1442-7. PubMed ID: 25039724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHA
    Kim TH; Yang PS; Kim D; Yu HT; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
    Stroke; 2017 Nov; 48(11):2984-2990. PubMed ID: 28939672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHA
    Kim TH; Yang PS; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
    Stroke; 2017 Jun; 48(6):1524-1530. PubMed ID: 28455320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of ischemic stroke and utility of CHA
    Tomasdottir M; Friberg L; Hijazi Z; Lindbäck J; Oldgren J
    Clin Cardiol; 2019 Oct; 42(10):1003-1009. PubMed ID: 31490011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart failure: a weak link in CHA
    Friberg L; Lund LH
    ESC Heart Fail; 2018 Jun; 5(3):231-239. PubMed ID: 29446254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHA
    Mlodawska E; Tomaszuk-Kazberuk A; Lopatowska P; Kaminski M; Musial WJ
    Intern Med J; 2017 Mar; 47(3):275-279. PubMed ID: 27860070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmented intelligence decision tool for stroke prediction combines factors from CHA
    Horne BD; Jacobs V; May HT; Graves KG; Bunch TJ
    J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1452-1461. PubMed ID: 31115939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting stroke in patients without atrial fibrillation.
    Steensig K; Olesen KKW; Thim T; Nielsen JC; Madsen M; Jensen SE; Jensen LO; Kristensen SD; Lip GYH; Maeng M
    Eur J Clin Invest; 2019 Jun; 49(6):e13103. PubMed ID: 30883728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS
    Katz DF; Maddox TM; Turakhia M; Gehi A; O'Brien EC; Lubitz SA; Turchin A; Doros G; Lei L; Varosy P; Marzec L; Hsu JC
    Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation.
    Chao TF; Lip GYH; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Chen SA
    J Am Coll Cardiol; 2018 Jan; 71(2):122-132. PubMed ID: 29325634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of the CHA
    Jaakkola S; Kiviniemi TO; Nuotio I; Hartikainen J; Mustonen P; Palomäki A; Jaakkola J; Ylitalo A; Hartikainen P; Airaksinen KEJ
    Am J Cardiol; 2018 May; 121(10):1182-1186. PubMed ID: 29526276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHA
    Su CH; Tsao TF; Chen AC; Chang KW; Yang YS; Ueng KC; Tsai CF
    Eur J Clin Invest; 2018 Mar; 48(3):. PubMed ID: 29288496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHA
    Jensen T; Thrane PG; Olesen KKW; Würtz M; Nielsen JC; Jensen LO; Madsen M; Thim T; Dalby Kristensen S; Lip GYH; Maeng M
    Eur J Clin Invest; 2022 Apr; 52(4):e13717. PubMed ID: 34792181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study.
    Toyoda K; Arihiro S; Todo K; Yamagami H; Kimura K; Furui E; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Hasegawa Y; Mochizuki H; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Kario K; Sato S; Koga M;
    Int J Stroke; 2015 Aug; 10(6):836-42. PubMed ID: 25581108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do CHA2 DS2 VASc and HAS-BLED scores influence 'real-world' anticoagulation management in atrial fibrillation? 1556 patient registry from the reference cardiology centre.
    Lopatowska P; Tomaszuk-Kazberuk A; Mlodawska E; Bachorzewska-Gajewska H; Malyszko J; Dobrzycki S; Musial WJ
    Pharmacoepidemiol Drug Saf; 2015 Dec; 24(12):1297-303. PubMed ID: 26419506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Use vs Discontinuation of Oral Anticoagulation After Pulmonary Vein Isolation in Patients With Atrial Fibrillation.
    Själander S; Holmqvist F; Smith JG; Platonov PG; Kesek M; Svensson PJ; Blomström-Lundqvist C; Tabrizi F; Tapanainen J; Poci D; Jönsson A; Själander A
    JAMA Cardiol; 2017 Feb; 2(2):146-152. PubMed ID: 27893055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translating claims-based CHA
    Webster-Clark M; Huang TY; Hou L; Toh S
    Pharmacoepidemiol Drug Saf; 2020 Apr; 29(4):409-418. PubMed ID: 32067286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.